Mesoblast (MESO) EBIT Growth (1y) (2016 - 2023)
Mesoblast (MESO) EBIT Growth (1y) (2016 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
1.27% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-347.04% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
0.07% |
| Mar 31, 2023 |
-22.50% |
| Dec 31, 2022 |
15.17% |
| Sep 30, 2022 |
71.71% |
| Jun 30, 2022 |
-57.48% |
| Mar 31, 2022 |
38.70% |
| Dec 31, 2021 |
-9,855.67% |
| Sep 30, 2021 |
-11,886.21% |
| Jun 30, 2021 |
219.98% |
| Mar 31, 2021 |
-38.64% |
| Dec 31, 2020 |
101.36% |
| Sep 30, 2020 |
102.33% |
| Jun 30, 2020 |
19,799.20% |
| Mar 31, 2020 |
-54.31% |
| Dec 31, 2019 |
-3.30% |
| Sep 30, 2019 |
37.21% |
| Jun 30, 2019 |
-36.01% |
| Mar 31, 2019 |
6.18% |
| Dec 31, 2018 |
48.77% |
| Sep 30, 2018 |
-3,875.65% |
